Tags: section:technologies, kind:bci-technology, topic:als, topic:motor-neuron-disease, topic:communication, topic:locked-in
Brain-computer interface (BCI) technology for amyotrophic lateral sclerosis (ALS) represents the most clinically advanced application of neural interfaces for neurodegenerative disease. ALS progressively destroys motor neurons, leading to complete paralysis while sparing cognitive function—a scenario that makes BCI not merely beneficial but potentially transformative for quality of life. BCI for ALS focuses primarily on communication, environmental control, and maintaining independence as the disease progresses[1].
Amyotrophic lateral sclerosis is characterized by:
Several factors make ALS an ideal target for BCI:
| Factor | Impact |
|---|---|
| Spared cognition | Patients can operate BCI with preserved intent |
| Progressive nature | BCI needs evolve as disease advances |
| Clear milestone | Locked-in state requires communication BCI |
| Existing infrastructure | Large patient networks and advocacy |
The P300 speller is the most studied communication BCI for ALS:
| Variant | Advantage | Disadvantage |
|---|---|---|
| Standard 6x6 | Familiar layout | Visual fatigue |
| Hex-o-spell | Faster selection | Learning curve |
| Center speller | Reduced eye movement | Lower accuracy |
| Auditory speller | For visual impairment | Slower |
SSVEP-based systems offer higher information transfer rates:
Motor imagery activates similar neural circuits as actual movement:
Motor imagery BCI can provide:
| Study | Patients | Application | Outcome |
|---|---|---|---|
| Wolpaw et al. | 8 ALS | Cursor control | 100% task success |
| Kübler et al. | 15 ALS | Communication | 70% accuracy |
| Daly et al. | 5 ALS | Wheelchair | Feasibility shown |
Invasive BCI offers higher signal quality than non-invasive methods:
| System | Developer | Electrodes | Status |
|---|---|---|---|
| Utah Array | Blackrock | 96-100 | Human trials |
| Neuralink | Neuralink | 1024 | First human 2024 |
| BrainGate | Consortium | 96-200 | Ongoing trials |
| NeuroPace | NeuroPace | Variable | Approved for epilepsy |
For patients in locked-in state (complete paralysis except for eye movement):
BCI provides critical functionality:
For patients who cannot use visual interfaces:
Even with cognitive impairment, certain approaches may work:
The most widely used assistive technology for ALS:
Combining multiple signals improves reliability:
| Platform | Modality | Features | Target Users |
|---|---|---|---|
| g.tec g.tec | EEG | High-precision | Research, clinical |
| Emotiv | EEG | Consumer-friendly | Home use |
| OpenBCI | EEG | Open-source | Developers |
| BrainProducts | EEG | Research-grade | Clinical trials |
| Platform | Developer | Clinical Status |
|---|---|---|
| Neuralink | Neuralink | First human trials |
| BrainGate | Academic | Long-term trials |
| Paradromics | Paradromics | Investigational |
| Synchron | Synchron | FDA approved |
| Measure | Improvement |
|---|---|
| Communication speed | 5-10x vs. eye-tracking alone |
| Depression scores | Reduced with effective BCI |
| Caregiver burden | Decreased with independence |
| Life satisfaction | Improved in longitudinal studies |
[Farwell & Donchin, P300 speller (1988)](https://doi.org/10.1016/0013-4694(88). 1988. ↩︎
Wolpaw et al. Motor imagery BCI (2002). 2002. ↩︎
Willett et al. Neural speech decoding (2021). 2021. ↩︎